MRK Stock Gains 3.80% on Wednesday, Momentum Weakens

Merck’s sharp one-day rise puts the drugmaker in focus for international investors: its stock gained 3.80%, about 1.6 times its average daily trading range, even as its broader trend remains sideways. The shares closed at $147.37, up from $141.98, according to market data via Yahoo Finance as of October 15, 2026. The move was not backed by unusually heavy trading, so the question is whether buyers can extend it or whether momentum indicators will hold the stock in its recent range.

Trend & Price Action

Merck has risen 3.21% over five trading days and 1.70% over one month, but its short-term trend is still classified as sideways. The price sits above both the 20-day simple moving average, or SMA, at $145.89 and the 50-day SMA at $144.43. That position is constructive: the shares are trading above their recent average levels. But there has been no fresh moving-average crossover, so the alignment does not yet establish a new trend. The 20-day average is nearly flat, with a slope of 0.02% over five days. In plain terms, the recent bounce has not yet changed the underlying direction. Merck is also in the upper half of its 20-day trading range, at 69% of the distance between support and resistance. Its three-month high and low are $156.92 and $122.75, respectively. As shown in the chart, the nearby reference points are the 20-day support at $139.54 and resistance at $150.91. The Bollinger middle band, another measure of the recent average price, is $145.89; the upper and lower bands are $151.89 and $139.88. The bands are at normal width, not unusually compressed or expanded.

Oscillators & Momentum

Momentum readings are mixed rather than decisively bullish. The 14-day Relative Strength Index (RSI), which gauges the pace of recent gains and losses, is 54.8, a neutral reading. Stochastic %K is 74.1 and %D is 49.9; the indicator is also classified as neutral. Neither measure signals that the price has moved to an extreme, though the higher %K shows stronger recent momentum than its comparison line. The MACD points the other way. Its reading is -0.201, below the -0.010 signal line, while the histogram is -0.191. This negative configuration means the trend-following momentum measure has yet to confirm the recent price rise. The gap does not prove the stock will fall, but it makes the one-day jump less convincing as a standalone trend signal.

Volatility & Trading Activity

Merck’s Average True Range (ATR), a measure of typical daily price movement, is $3.55, or 2.4% of the latest price—consistent with moderate volatility. The day’s 3.80% advance was larger than that usual range, marking a notable move rather than routine trading. Volume was 9,799,700 shares, roughly in line with the 20-day average of 10,056,020. That matters: the gain came without a clear surge in participation. On the other hand, On-Balance Volume (OBV), which tracks whether volume tends to accompany rising or falling prices, is increasing. The combination suggests buyers have been present, but the latest session did not bring unusually strong confirmation.

Key Levels & Scenarios

A move through $150.91 resistance would challenge the recent ceiling and bring the upper Bollinger band at $151.89 into view as a separate reference level. A sustained break above those levels would strengthen the case that the advance is becoming more than a short-lived bounce. If the shares fail to hold the SMA20 at $145.89 and SMA50 at $144.43, traders would have reason to watch the $139.54 support area; the lower Bollinger band is nearby at $139.88.

Technical Verdict: HOLD (wait & see)

HOLD (wait & see) is the technical verdict: the price is above both moving averages and OBV is rising, but the flat SMA20, neutral RSI and Stochastic, and negative MACD leave the strength of the breakout unconfirmed. The verdict is invalidated if the price falls below $139.54, the 20-day support level. - Entry range: $144.43–$145.89, around the SMA50 and SMA20, as a reference zone rather than a forecast. - Exit target: $150.91–$151.89, spanning the 20-day resistance and upper Bollinger band. - Stop-loss protection: Below $139.54, the 20-day support level. For non-traders, this means Merck’s chart has improved, but its indicators have not yet confirmed a durable upward move.

Data: Market data via Yahoo Finance, as of October 15, 2026, 03:03 WIB.

Summary Data MRK

Last price	147.37 USD
Change 1 day / 5 days / 1 month	3.80% / 3.21% / 1.70%
Trend / MA-cross	sideways / none
SMA20 / SMA50	145.89 / 144.43
RSI (14) / Stochastic %K	54.8 / 74.1
Bollinger %B / ATR	62% / 3.55
Support / Resistance 20 days	139.54 / 150.91
Data as of	15 October 2026 03:03 WIB

Disclaimer: This technical analysis is generated automatically from exchange data (via Yahoo Finance) and indicators calculated by JournalArta, for information and education only. The verdict and the entry, target and stop-loss levels are not investment advice or a solicitation to buy or sell any security. Investment decisions and their risks rest solely with the reader.